Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · IEX Real-Time Price · USD
1.090
+0.030 (2.83%)
Apr 23, 2024, 4:00 PM EDT - Market closed

Oragenics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2002
Net Income
-20.66-14.29-15.71-26.43-15.57-11.33-6.73-7.01-11.71-5.79
Upgrade
Depreciation & Amortization
0.030.040.040.050.060.030.070.080.070.03
Upgrade
Share-Based Compensation
1.020.741.691.490.551.020.560.641.030.29
Upgrade
Other Operating Activities
12.32-1.730.517.931.94-0.22-0.26-0.785.42-0.08
Upgrade
Operating Cash Flow
-7.29-15.23-13.47-16.95-13.01-9.08-6.36-7.08-5.19-5.56
Upgrade
Capital Expenditures
0.06-0.12-0.040-0.03-0.120-0.02-0.1-0.11
Upgrade
Acquisitions
-10000001.4500
Upgrade
Change in Investments
00000000.2500
Upgrade
Investing Cash Flow
-0.94-0.12-0.040-0.03-0.1201.68-0.1-0.11
Upgrade
Share Issuance / Repurchase
0.850.0729.316.5211.3523.450.034.6100
Upgrade
Debt Issued / Paid
-0.57-0.56-0.52-0.2-0.25-0.22.24-0.16-0.16-0.16
Upgrade
Other Financing Activities
---5.64---6.18---
Upgrade
Financing Cash Flow
0.28-0.4923.1416.3211.123.258.454.45-0.16-0.16
Upgrade
Net Cash Flow
-7.94-15.849.63-0.63-1.9414.042.09-0.95-5.45-5.83
Upgrade
Free Cash Flow
-7.23-15.34-13.51-16.95-13.04-9.2-6.36-7.1-5.29-5.67
Upgrade
Free Cash Flow Margin
-19194.13%-11666.58%-15535.76%-------603.17%
Upgrade
Free Cash Flow Per Share
-3.21-7.64-6.96-17.99-18.50-42.35-77.51-95.50-86.60-94.09
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).